These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 12203137

  • 1. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).
    Koç ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W.
    Bone Marrow Transplant; 2002 Aug; 30(4):215-22. PubMed ID: 12203137
    [Abstract] [Full Text] [Related]

  • 2. Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report.
    Meuleman N, Vanhaelen G, Tondreau T, Lewalle P, Kwan J, Bennani J, Martiat P, Lagneaux L, Bron D.
    Haematologica; 2008 Jan; 93(1):e11-3. PubMed ID: 18166768
    [Abstract] [Full Text] [Related]

  • 3. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Moseley AB, Bacigalupo A.
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [Abstract] [Full Text] [Related]

  • 4. In vitro analysis of multipotent mesenchymal stromal cells as potential cellular therapeutics in neurometabolic diseases in pediatric patients.
    Müller I, Kustermann-Kuhn B, Holzwarth C, Isensee G, Vaegler M, Harzer K, Krägeloh-Mann I, Handgretinger R, Bruchelt G.
    Exp Hematol; 2006 Oct; 34(10):1413-9. PubMed ID: 16982334
    [Abstract] [Full Text] [Related]

  • 5. Outcome of second hematopoietic cell transplantation in Hurler syndrome.
    Grewal SS, Krivit W, Defor TE, Shapiro EG, Orchard PJ, Abel SL, Lockman LA, Ziegler RS, Dusenbery KE, Peters C.
    Bone Marrow Transplant; 2002 Mar; 29(6):491-6. PubMed ID: 11960268
    [Abstract] [Full Text] [Related]

  • 6. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation.
    Rieger K, Marinets O, Fietz T, Körper S, Sommer D, Mücke C, Reufi B, Blau WI, Thiel E, Knauf WU.
    Exp Hematol; 2005 May; 33(5):605-11. PubMed ID: 15850839
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K, Al-Ali H, Reinhardt A, Franke C, Hudecek M, Kamprad M, Tschiedel S, Cross M, Niederwieser D, Gentilini C.
    Transplantation; 2009 Jan 27; 87(2):217-21. PubMed ID: 19155975
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats.
    Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC.
    Exp Neurol; 2002 Mar 27; 174(1):11-20. PubMed ID: 11869029
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases].
    Maaswinkel-Mooij PD, Poorthuis BJ, Hoogerbrugge PM, Brouwer OF, Vossen JM.
    Ned Tijdschr Geneeskd; 1998 Jan 24; 142(4):169-74. PubMed ID: 9557021
    [Abstract] [Full Text] [Related]

  • 14. Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation.
    Pozzi S, Lisini D, Podestà M, Bernardo ME, Sessarego N, Piaggio G, Cometa A, Giorgiani G, Mina T, Buldini B, Maccario R, Frassoni F, Locatelli F.
    Exp Hematol; 2006 Jul 24; 34(7):934-42. PubMed ID: 16797421
    [Abstract] [Full Text] [Related]

  • 15. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE, Horibe E, Sacks J, Ikeguchi R, Breitinger J, Scozio M, Unadkat J, Feili-Hariri M.
    Clin Immunol; 2008 Jun 24; 127(3):348-58. PubMed ID: 18387852
    [Abstract] [Full Text] [Related]

  • 16. The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-I.
    Fleming DR, Henslee-Downey PJ, Ciocci G, Romond EH, Marciniak E, Munn RK, Thompson JS.
    Pediatr Transplant; 1998 Nov 24; 2(4):299-304. PubMed ID: 10084733
    [Abstract] [Full Text] [Related]

  • 17. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G, Gustafsson B, Berglund G, Lindström M, Naess K, Borgström B, von Döbeln U, Ringdén O.
    Acta Paediatr; 2008 Aug 24; 97(8):1108-12. PubMed ID: 18452566
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation.
    Malm G, Ringdén O, Winiarski J, Gröndahl E, Uyebrant P, Eriksson U, Håkansson H, Skjeldal O, Månsson JE.
    Bone Marrow Transplant; 1996 Jun 24; 17(6):1003-8. PubMed ID: 8807106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.